These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

355 related articles for article (PubMed ID: 19226359)

  • 1. Nocturia: a non-specific but important symptom of urological disease.
    Schneider T; de la Rosette JJ; Michel MC
    Int J Urol; 2009 Mar; 16(3):249-56. PubMed ID: 19226359
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Desmopressin add-on therapy for refractory nocturia in men receiving α-blockers for lower urinary tract symptoms.
    Bae WJ; Bae JH; Kim SW; Chung BH; Kim JH; Kim CS; Lee HM; Lee KS; Yoo TK; Kim SI; Byun SS; Lee JY
    J Urol; 2013 Jul; 190(1):180-6. PubMed ID: 23357213
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Age related pathogenesis of nocturia in patients with overactive bladder.
    Weiss JP; Blaivas JG; Jones M; Wang JT; Guan Z;
    J Urol; 2007 Aug; 178(2):548-51; discussion 551. PubMed ID: 17570424
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathophysiological aspects of nocturia in a danish population of men and women age 60 to 80 years.
    Bing MH; Moller LA; Jennum P; Mortensen S; Lose G
    J Urol; 2007 Aug; 178(2):552-7. PubMed ID: 17570415
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nocturia in older men.
    van Doorn B; Bosch JL
    Maturitas; 2012 Jan; 71(1):8-12. PubMed ID: 22079871
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical efficacy of an alpha1A/D-adrenoceptor blocker (naftopidil) on overactive bladder symptoms in patients with benign prostatic hyperplasia.
    Takahashi S; Tajima A; Matsushima H; Kawamura T; Tominaga T; Kitamura T
    Int J Urol; 2006 Jan; 13(1):15-20. PubMed ID: 16448426
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nocturia: an Austrian study on the multifactorial etiology of this symptom.
    Klingler HC; Heidler H; Madersbacher H; Primus G
    Neurourol Urodyn; 2009; 28(5):427-31. PubMed ID: 19229953
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thinking beyond the bladder: antidiuretic treatment of nocturia.
    van Kerrebroeck P; Hashim H; Holm-Larsen T; Robinson D; Stanley N
    Int J Clin Pract; 2010 May; 64(6):807-16. PubMed ID: 20337753
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detrusor overactivity persisting at night and preceding nocturia in patients with overactive bladder syndrome: a nocturnal cystometrogram and polysomnogram study.
    Krystal AD; Preud'homme XA; Amundsen CL; Webster GD
    J Urol; 2010 Aug; 184(2):623-8. PubMed ID: 20639027
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Demystifying nocturia: identifying the cause and tailoring the treatment.
    Laureanno P; Ellsworth P
    Urol Nurs; 2010; 30(5):276-86; quiz 287. PubMed ID: 21067093
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of the prognostic factors for overactive bladder symptoms following surgical treatment in patients with benign prostatic obstruction.
    Seki N; Yuki K; Takei M; Yamaguchi A; Naito S
    Neurourol Urodyn; 2009; 28(3):197-201. PubMed ID: 18973143
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beneficial effect of intranasal desmopressin for men with benign prostatic hyperplasia and nocturia: preliminary results.
    Chancellor MB; Atan A; Rivas DA; Watanabe T; Tai HL; Kumon H
    Tech Urol; 1999 Dec; 5(4):191-4. PubMed ID: 10591256
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effectiveness of tamsulosin hydrochloride and its mechanism in improving nocturia associated with lower urinary tract symptoms/benign prostatic hyperplasia.
    Yoshida M; Inadome A; Masunaga K; Nagata T; Yoshiyasu T
    Neurourol Urodyn; 2010 Sep; 29(7):1276-81. PubMed ID: 20878997
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Defining the role of overactive bladder treatments in men with lower urinary tract symptoms.
    Lemack GE
    Nat Clin Pract Urol; 2007 Apr; 4(4):174-5. PubMed ID: 17415351
    [No Abstract]   [Full Text] [Related]  

  • 15. Nocturia: etiology, diagnosis, and treatment.
    Appell RA; Sand PK
    Neurourol Urodyn; 2008; 27(1):34-9. PubMed ID: 17924538
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nocturia in women.
    Robinson D
    Int J Clin Pract Suppl; 2007 Sep; (155):23-31. PubMed ID: 17727576
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of urgency, frequency, and nocturia in defining overactive bladder adaptive behavior.
    Minassian V; Stewart W; Hirsch A; Kolodner K; Fitzgerald M; Burgio K; Cundiff G; Blaivas J; Newman D; Dilley A
    Neurourol Urodyn; 2011 Mar; 30(3):406-11. PubMed ID: 21412822
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of naftopidil on nocturia after failure of tamsulosin.
    Oh-oka H
    Urology; 2008 Nov; 72(5):1051-5. PubMed ID: 18817955
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Impact of nocturia on the daily life of patients with lower urinary tract symptoms due to benign prostatic hyperplasia].
    Cornu JN; RouprĂȘt M
    Prog Urol; 2007 Sep; 17(5 Suppl 1):1033-6. PubMed ID: 17969786
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current pharmacotherapy of nocturia.
    Smith A; Wein A
    Expert Opin Pharmacother; 2013 May; 14(7):885-94. PubMed ID: 23556416
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.